Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range

MUTLU N., Turkeri L. N., YENCİLEK F., Demir A., Emerk K.

CANADIAN JOURNAL OF UROLOGY, vol.16, no.2, pp.4558-4567, 2009 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 2
  • Publication Date: 2009
  • Journal Name: CANADIAN JOURNAL OF UROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.4558-4567
  • Marmara University Affiliated: Yes

Abstract

Background: Data on utilizing complexed prostate specific antigen (cPSA) offering increased diagnostic performance over other available clinical parameters in diagnosis of prostate cancer is still controversial. Our objective was to determine diagnostic performance of cPSA compared to total prostate specific antigen (tPSA) mid corresponding ratios for possible routine application.